Portea Medical Expands Cancer Care Services Across India

New Delhi, August 6, 2025 — Portea Medical, India’s leading home healthcare provider, has announced the nationwide expansion of its comprehensive cancer care services. The initiative aims to ease access for oncology patients by offering treatment, monitoring, and palliative care at home — a significant relief for patients undergoing chemotherapy, radiotherapy, and post-treatment support.

This move comes as India witnesses a sharp rise in cancer cases. The need for decentralized, home-based services is more urgent than ever. According to the Indian Council of Medical Research (ICMR), India is projected to witness over 15 lakh new cancer cases in 2025. Many patients, particularly those in Tier 2 and Tier 3 cities, lack access to continuous, affordable, and high-quality cancer care.

Services Now Offered Across Cities

Portea Medical will now provide services in Delhi NCR, Bengaluru, Hyderabad, Chennai, Mumbai, and several smaller towns. These include:

  • Chemotherapy and medication administration

  • IV infusions and wound care

  • Nutrition counseling

  • Pain management

  • Oncologist-led virtual consultations

  • Emotional support and palliative care

The model has been piloted over the last year and, after positive outcomes and feedback, is now being scaled up.

Why It Matters

Cancer treatment is often long, exhausting, and disruptive. Families face financial and emotional stress. Traveling to hospitals multiple times weekly is painful — especially for terminally ill or elderly patients.

Home-based models are known to improve treatment compliance, reduce hospital-acquired infections, and help patients maintain dignity during advanced stages.

Dr. Vishal Sehgal, President of Portea Medical, said, “We want to bring compassionate care to patients’ doorsteps. Cancer is not just a medical battle — it’s a mental and emotional journey. Our teams are trained to support families throughout.”

Dr. Rajesh Chopra, senior oncologist at Max Healthcare, welcomed the initiative. “This aligns with global standards where home infusion therapy and palliative care are integral. India needs more such models, particularly in semi-urban regions.”

While India’s National Cancer Grid and public hospitals have expanded infrastructure, access remains unequal. Tele-oncology and home health tech platforms are being seen as the next wave in patient-centered cancer treatment.

According to Frost & Sullivan, India’s home healthcare market is expected to reach ₹7,000 crore by 2026, driven largely by chronic diseases like cancer, diabetes, and heart conditions.

Portea Medical’s initiative is expected to serve over 20,000 oncology patients in the next 12 months.

For full details, visit: medicarepharmabusiness.com

Related Posts

Ajanta Pharma Promoter Sell 3% Stake Worth ₹1,024 Crore; Shares Trade Higher

Mumbai: A promoter entity of Ajanta Pharma Ltd. on Tuesday offloaded a nearly 3% stake in the company through open market transactions, even as domestic institutional investors stepped in to absorb a large…

FDA cracks down on illegal drug trade, stock worth about ₹25 lakh seized from Pune and Kolhapur

Pune: In a major crackdown against illegal pharmaceutical activities that compromise public health, the Food and Drug Administration (FDA) has seized a stock of medicines worth above Rs24.81 lakh from…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Ajanta Pharma Promoter Sell 3% Stake Worth ₹1,024 Crore; Shares Trade Higher

Ajanta Pharma Promoter Sell 3% Stake Worth ₹1,024 Crore; Shares Trade Higher

FDA cracks down on illegal drug trade, stock worth about ₹25 lakh seized from Pune and Kolhapur

FDA cracks down on illegal drug trade, stock worth about ₹25 lakh seized from Pune and Kolhapur

ICMR-NIN study links micronutrient deficiencies to higher dementia risk

ICMR-NIN study links micronutrient deficiencies to higher dementia risk

Pvt nursing home sealed in Chatra after woman, unborn baby die

Pvt nursing home sealed in Chatra after woman, unborn baby die

30 docs from 9 states guilty of taking pharma company junket, no action yet by 6 state medical councils

30 docs from 9 states guilty of taking pharma company junket, no action yet by 6 state medical councils

Scheme to build bulk drugs’ R&D, capacity in works, says Pharma secy

Scheme to build bulk drugs’ R&D, capacity in works, says Pharma secy